Company intelligence / Profile preview

Oncoheroes Biosciences

Brookline/Boston*, Massachusetts, United Statesoncoheroes.com ↗

Ownership: Private
Development stage: Other

Overview

Oncoheroes Biosciences has advanced two main assets—dovitinib and volasertib—both of which have received Orphan Drug Designation and Rare Pediatric Disease Designation from the FDA. Dovitinib has FDA IND clearance to proceed with trials in advanced or relapsed pediatric solid tumors, including osteosarcoma. Volasertib has completed Phase I studies as a single agent in children with leukemia/refractory solid tumors; further clinical evaluation in rhabdomyosarcoma is planned. The company’s proprietary screening platform supports identification of new drug candidates specifically for childhood cancers.

Therapeutic areas: Oncology
Modalities: Small molecules (e.g., dovitinib, volasertib)Targeted therapies/kinase inhibitorsProprietary pediatric screening platform
Industry: Biotech

Drug pipeline

1 asset

volasertib

Partnerships

Novartis (exclusive worldwide license for dovitinib)Boehringer Ingelheim (exclusive worldwide license for volasertib)collaborations with international pediatric oncology networks

Beyond the preview

Go deeper on Oncoheroes Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oncoheroes Biosciences.